SELLAS Life Sciences Group, Inc. (SLS)
5.46
+0.15
(+2.82%)
USD |
NASDAQ |
Mar 04, 15:02
SELLAS Life Sciences Group Research and Development Expense (TTM) : 15.73M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| GT Biopharma, Inc. | -- |
| Amicus Therapeutics, Inc. | 135.84M |
| Geron Corp. | 73.72M |
| Vanda Pharmaceuticals, Inc. | 109.27M |
| ADMA Biologics, Inc. | 4.761M |